25th May 2023
23rd May 2023
ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine
11th May 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”
27th April 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital
13th April 2023